Finoriq research workspace
ZIMMER BIOMET HOLDINGS, INC. (ZBH) SEC Filings & Filing Highlights
Zimmer Biomet Holdings, Inc. operates as a medical technology company worldwide. Review ZBH SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
- Company
- ZIMMER BIOMET HOLDINGS, INC. (ZBH)
- Ticker
- ZBH
- Market Cap
- $17.4B
- Latest Price
- $90.02
- Industry
- Industrial Specialties
ZIMMER BIOMET HOLDINGS, INC. (ZBH) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for ZIMMER BIOMET HOLDINGS, INC. (ZBH).
| Event | Form | Date |
|---|---|---|
| Debt or FinancingDebt or Financing | 8-K2.03 | 2026-06-29 |
| ZIMMER BIOMET HOLDINGS, INC.: Agreement terminationIn connection with the entry into the Five-Year Credit Agreement and the 364-Day Credit Agreement, on June 26, 2026, the Five-Year Revolvin... | 8-K1.02 | 2026-06-29 |
| On June 26, 2026, Zimmer Biomet Holdings, Inc. entered into a new five-year revolving credit ag...On June 26, 2026, Zimmer Biomet Holdings, Inc. (the “Company”) entered into a new five-year revolving credit agreement and a new 364-day re... | 8-K1.01 | 2026-06-29 |
| Zimmer Biomet Holdings, Inc. held its annual meeting of shareholders on May 22, 2026. Sharehold...Zimmer Biomet Holdings, Inc. (the “Company”) held its annual meeting of shareholders on May 22, 2026. Shareholders took the following actio... | 8-K5.07 | 2026-05-27 |
| Zimmer Biomet Increases Share Repurchase Expectations — Up to $1 Billion by Year EndZimmer Biomet Increases Share Repurchase Expectations — Up to $1 Billion by Year End | 8-K7.01 | 2026-05-12 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.